Compound Detail
CHEMBL2178284
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2178284 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QUHARGDBJJUOEB-UHFFFAOYSA-N |
2
Targets
5
Activities
1
Assay Types
19
PK Parameters
20
Publications
0
Known Names
Molecular Properties
293.3
MW (Da)
3.12
ALogP
3
HBA
2
HBD
72.5
PSA (Ų)
0.91
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 7.92
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI CHEMBL3994 | IC50 | 7.92 | 7.92 | 12.0 | 3 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI CHEMBL1857 | IC50 | 7.24 | 7.24 | 58.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 18393.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 23920.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 27635.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 20262.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 105067.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 13936.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 106.67 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 28900.0 | ng/g | Rattus norvegicus |
| Cmax | 42100.0 | ng/g | Rattus norvegicus |
| Cmax | 37800.0 | ng/g | Rattus norvegicus |
| Cmax | 63000.0 | ng/g | Rattus norvegicus |
| Cmax | 51700.0 | ng/g | Rattus norvegicus |
| Cmax | 103795.14 | nM | Rattus norvegicus |
| T1/2 | 5.9 | hr | Rattus norvegicus |
| T1/2 | 5.0 | hr | Rattus norvegicus |
| T1/2 | 4.2 | hr | Rattus norvegicus |
| T1/2 | 8.5 | hr | Rattus norvegicus |
| T1/2 | 9.2 | hr | Rattus norvegicus |
| T1/2 | 4.9 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 23092194 | 10.1021/jm301113w | Staphylococcus aureus | 12 |
| 23092194 | 10.1021/jm301113w | Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | 4 |
| 32883635 | 10.1016/j.ejmech.2020.112757 | Staphylococcus aureus | 4 |
| 23092194 | 10.1021/jm301113w | Rattus norvegicus | 4 |
| 23092194 | 10.1021/jm301113w | Brain | 3 |
| 23092194 | 10.1021/jm301113w | No relevant target | 3 |
| 23092194 | 10.1021/jm301113w | Canis familiaris | 3 |
| 23092194 | 10.1021/jm301113w | Plasma | 3 |
| 23092194 | 10.1021/jm301113w | Liver | 3 |
| 23092194 | 10.1021/jm301113w | Kidney | 3 |
| 23092194 | 10.1021/jm301113w | Heart | 3 |
| 23092194 | 10.1021/jm301113w | Lung | 3 |
| 32883635 | 10.1016/j.ejmech.2020.112757 | Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | 2 |
| - | 10.6019/CHEMBL4513161 | Pseudomonas aeruginosa | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 32883635 | 10.1016/j.ejmech.2020.112757 | Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 2 |
| 23092194 | 10.1021/jm301113w | Escherichia coli | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 23092194 | 10.1021/jm301113w | Neisseria meningitidis | 1 |
| 23092194 | 10.1021/jm301113w | Haemophilus influenzae | 1 |
Data from ChEMBL 36 via Core Engine